ANAB
ANAPTYSBIO, INC
NASDAQ · Healthcare · Biotechnology · US
$47.39
−0.71%Forward multiples
Based on analyst estimates
- P/E forward
- 5.26x
- P/E 2026E
- 9.24x
- P/E 2027E
- 6.95x
- P/E 2028E
- 6.59x
- P/S forward
- 8.12x
Trailing multiples
Trailing twelve months
- P/E TTM
- 7.02x
- PEG TTM
- 0.21x
- Price / book
- 133.84x
- Price / sales
- 5.96x
- Price / cash flow
- 78.35x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 6.41x
- EV / EBITDA
- 16.56x
- EV / EBIT
- 11.37x
- Market cap
- $1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026